Screening pulmonary hypertension patients for depression

International Journal of Clinical Practice

Volumn 65, Issue SUPPL. 174, 2011, Pages 4-5

  McCollister, Deborah H ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

COMORBIDITY; DEPRESSION; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; PATIENT ASSESSMENT; PATIENT CARE; PATIENT CARE PLANNING; PATIENT COMPLIANCE; PATIENT HEALTH QUESTIONNAIRE 2; PATIENT HEALTH QUESTIONNAIRE 8; PATIENT HEALTH QUESTIONNAIRE 9; PATIENT REFERRAL; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUESTIONNAIRE; REVIEW; SYMPTOM;

EID: 84055188752     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2011.02821.x     Document Type: Review

References (14)

1. Simonneau G, Rubin LJ, Galie N, et al., Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial. Ann Intern Med 2008; 149: 521-30.
2. Farber HW, Loscalzo J,. Pulmonary arterial hypertension. N Engl J Med 2004; 351: 1655-65.
3. McLaughlin VV, McGoon MD,. Pulmonary arterial hypertension. Circulation 2006; 114: 1417-31. (Pubitemid 44454562)
4. McLaughlin V, Humbert M, Coghlan G, et al., Pulmonary arterial hypertension: the most devastating vascular complication of systemic sclerosis. Rheumatology (Oxford) 2009; 48 (Suppl. 3): iii25-31.
5. Badesch DB, Abman SH, Simonneau G, et al., Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 2007; 131: 1917-28. (Pubitemid 46981654)
6. McLaughlin VV, Archer SL, Badesch DB, et al., ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009; 53: 1573-619.
7. Kendler KS, Karkowski LM, Prescott CA,. Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 1999; 156: 837-41. (Pubitemid 29260336)
8. Adams K, Corrigan J, eds. Priority Areas for National Action: Transforming Health Care Quality. Washington, DC: The National Academies Press, 2003; pp. 74-5.
9. Badesch DB, Raskob GE, Elliott CG, et al., Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 2010; 137: 376-87.
10. Hill W AC, Durst L, Scovel P, Beery F, Turner M, McGoon MD,. Predicting medical disability in patients with pulmonary arterial hypertension. Am Rev Respir Crit Care Med 2011; 183: A5940.
11. McCollister DH, Beutz M, McLaughlin V, et al., Depressive symptoms in pulmonary arterial hypertension: prevalence and association with functional status. Psychosomatics 2010; 51: 339-339, e8.
12. Kroenke K, Strine TW, Spitzer RL, et al., The PHQ-8 as a measure of current depression in the general population. J Affect Disord 2009; 114: 163-73.
13. Kroenke K, Spitzer RL, Williams JB,. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-13. (Pubitemid 32823891)
14. Kroenke K, Spitzer RL, Williams JB,. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 2003; 41: 1284-92.